Patent 7640062 was granted and assigned to Brainsgate on December, 2009 by the United States Patent and Trademark Office.
A method is provided for treating Alzheimer's disease (AD). The method includes stimulating a sphenopalatine ganglion (SPG) of a subject so that the concentration of a substance in a brain of the subject changes.